DiscoveRx, Jubilant Biosys Enter Co-Marketing Pact

Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd. based in Bangalore India, has entered into a co-marketing agreement with Fremont, CA-based DiscoveRx Corp. to provide screening solutions. DiscoveRx provides cell-based assay solutions for GPCR, Kinases, NHR and Proteases.

This agreement allows Jubilant access to DiscoveRx PathHunter and cAMPHunter cell lines and EFC chemiluminescent detection technology to perform screening on behalf of Jubilant clients. The agreement also allows DiscoverX to expand its platform technology to offer screening solutions from India.

Dr. Kailash Swarna, chief operating officer, Global Drug Discovery, at Jubilant Biosys, said, “We are pleased to announce this agreement with DiscoveRx, and look forward to the prospect of providing value to our customers using DiscoveRx PathHunter and HitHunter technologies. This partnership continues to demonstrate Jubilant’s mission to partner with leading technology providers that provide access to cutting edge and innovative solutions to accelerate global drug discovery efforts with our collaborators.”

Pyare Khanna, president and chief executive officer of DiscoveRx, said, “DiscoveRx constantly strives to provide our truly innovative solutions to screening community. We are determined to help expedite the drug discovery processes and are delighted with this relationship with Jubilant. Our customers require an easy access to our innovative product portfolio and such partnerships will add value to our efforts of bringing industry leading portfolio of PathHunter and HitHunter GPCR assays to a broader audience.”

Click here for more information about Jubilant